# Use of Topical Solasodine of Solanum Melongena Peel Origin in the Treatment of Palmar Arsenic Keratosis

> **NCT04693000** · PHASE2 · UNKNOWN · sponsor: **Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh** · enrollment: 20 (actual)

## Conditions studied

- Keratotic Nodular Size

## Interventions

- **DRUG:** Arsenic Keratosis lesion or nodular size observation after 12 weeks of therapy with solasodine ointment

## Key facts

- **NCT ID:** NCT04693000
- **Lead sponsor:** Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-09-23
- **Primary completion:** 2021-01-15
- **Final completion:** 2021-01-15
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2021-01-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04693000

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04693000, "Use of Topical Solasodine of Solanum Melongena Peel Origin in the Treatment of Palmar Arsenic Keratosis". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04693000. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*